Literature DB >> 12385647

Involvement of phospholipase D in insulin-like growth factor-I-induced activation of extracellular signal-regulated kinase, but not phosphoinositide 3-kinase or Akt, in Chinese hamster ovary cells.

Yoshiko Banno1, Yoh Takuwa, Momoko Yamada, Noriko Takuwa, Kenji Ohguchi, Akira Hara, Yoshinori Nozawa.   

Abstract

Available evidence suggests the involvement of phospholipase D (PLD) in cell proliferation and survival. Phosphoinositide 3-kinase (PI 3-kinase)/Akt and extracellular signal-regulated kinases (ERKs) are signalling molecules that have essential roles in cell proliferation and survival. We previously demonstrated that sphingosine 1-phosphate (S1P)-induced PLD activation via the G-protein-coupled receptor endothelial differentiation gene (EDG) 3/S1P(3) was involved in S1P-induced stimulation of PI 3-kinase and Akt. In the present study, we examined the involvement of two PLD isozymes, PLD1 and PLD2, in insulin-like growth factor (IGF)-I receptor tyrosine kinase-mediated stimulation of PI 3-kinase/Akt and ERKs. IGF-I and to a lesser degree S1P stimulated PI 3-kinase activity in Chinese hamster ovary cells overexpressing EDG3/S1P(3). IGF-I-induced ERK phosphorylation was suppressed by butan-1-ol, but not butan-2-ol, whereas no effect of butanol was observed in IGF-I-induced Akt activation in S1P(3)-overexpressing Chinese hamster ovary cells. Overexpression of wild-type PLD1 and PLD2 substantially potentiated S1P-, but not IGF-I-, induced activation of PI 3-kinase and Akt, whereas overexpression of the catalytically inactive mutant of PLD1 or PLD2 did not affect the responses to either agonist. On the other hand, overexpression of wild-type PLD1 and PLD2 potentiated IGF-I- and, to much smaller extents, S1P-induced ERK stimulation. ERK activation by IGF-I as well as S1P was dependent on Ras, but Akt activation by IGF-I was not dependent on Ras. These results suggest that PLDs are involved in growth factor regulation of at least two signalling pathways, PI 3-kinase/Akt and ERKs, depending on the class of cell-surface receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12385647      PMCID: PMC1223093          DOI: 10.1042/BJ20021368

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.

Authors:  H Okamoto; N Takuwa; T Yokomizo; N Sugimoto; S Sakurada; H Shigematsu; Y Takuwa
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Enhancement of lysophosphatidic acid-induced ERK phosphorylation by phospholipase D1 via the formation of phosphatidic acid.

Authors:  J H Hong; S O Oh; M Lee; Y R Kim; D U Kim; G M Hur; J H Lee; K Lim; B D Hwang; S K Park
Journal:  Biochem Biophys Res Commun       Date:  2001-03       Impact factor: 3.575

Review 3.  Phospholipase D: molecular and cell biology of a novel gene family.

Authors:  M Liscovitch; M Czarny; G Fiucci; X Tang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

4.  ATP-induced mitogenesis is modulated by phospholipase D2 through extracellular signal regulated protein kinase dephosphorylation in rat pheochromocytoma PC12 cells.

Authors:  C S Lee; Y S Bae; S D Lee; P G Suh; S H Ryu
Journal:  Neurosci Lett       Date:  2001-11-09       Impact factor: 3.046

5.  Involvement of phospholipase D in sphingosine 1-phosphate-induced activation of phosphatidylinositol 3-kinase and Akt in Chinese hamster ovary cells overexpressing EDG3.

Authors:  Y Banno; Y Takuwa; Y Akao; H Okamoto; Y Osawa; T Naganawa; S Nakashima; P G Suh; Y Nozawa
Journal:  J Biol Chem       Date:  2001-07-23       Impact factor: 5.157

6.  Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation.

Authors:  A Honda; M Nogami; T Yokozeki; M Yamazaki; H Nakamura; H Watanabe; K Kawamoto; K Nakayama; A J Morris; M A Frohman; Y Kanaho
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

7.  The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells.

Authors:  Q Xu; Z Wu
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

Review 8.  Sphingosine 1-phosphate signalling in mammalian cells.

Authors:  S Pyne; N J Pyne
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

9.  Differential phospholipase D activation by bradykinin and sphingosine 1-phosphate in NIH 3T3 fibroblasts overexpressing gelsolin.

Authors:  Y Banno; H Fujita; Y Ono; S Nakashima; Y Ito; N Kuzumaki; Y Nozawa
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

10.  A novel role for phosphatidylinositol 3-kinase beta in signaling from G protein-coupled receptors to Akt.

Authors:  C Murga; S Fukuhara; J S Gutkind
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

View more
  10 in total

Review 1.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

Review 2.  Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).

Authors:  David A Foster; Darin Salloum; Deepak Menon; Maria A Frias
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

3.  Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.

Authors:  Li Hui; Tarek Abbas; Rafal M Pielak; Troy Joseph; Jill Bargonetti; David A Foster
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

4.  PLD2 has both enzymatic and cell proliferation-inducing capabilities, that are differentially regulated by phosphorylation and dephosphorylation.

Authors:  Karen M Henkels; Stephen Short; Hong-Juan Peng; Mauricio Di Fulvio; Julian Gomez-Cambronero
Journal:  Biochem Biophys Res Commun       Date:  2009-08-26       Impact factor: 3.575

5.  HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

Authors:  Jerzy-Roch Nofer; Markus van der Giet; Markus Tölle; Iza Wolinska; Karin von Wnuck Lipinski; Hideo A Baba; Uwe J Tietge; Axel Gödecke; Isao Ishii; Burkhard Kleuser; Michael Schäfers; Manfred Fobker; Walter Zidek; Gerd Assmann; Jerold Chun; Bodo Levkau
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 6.  The mechanical activation of mTOR signaling: an emerging role for late endosome/lysosomal targeting.

Authors:  Brittany L Jacobs; Craig A Goodman; Troy A Hornberger
Journal:  J Muscle Res Cell Motil       Date:  2013-10-29       Impact factor: 2.698

7.  Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells.

Authors:  Momoko Yamada; Yoshiko Banno; Yoh Takuwa; Masahiro Koda; Akira Hara; Yoshinori Nozawa
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 8.  New concepts in phospholipase D signaling in inflammation and cancer.

Authors:  Julian Gomez-Cambronero
Journal:  ScientificWorldJournal       Date:  2010-07-07

9.  Genome-wide association study and pathway analysis identify NTRK2 as a novel candidate gene for litter size in sheep.

Authors:  Seyed Mehdi Esmaeili-Fard; Mohsen Gholizadeh; Seyed Hasan Hafezian; Rostam Abdollahi-Arpanahi
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

10.  Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC.

Authors:  Young-Rae Kim; Hee Sun Byun; Minho Won; Kyeong Ah Park; Jin Man Kim; Byung Lyul Choi; Hyunji Lee; Jang Hee Hong; Jongsun Park; Jeong Ho Seok; Dong Wook Kim; Minho Shong; Seung-Kiel Park; Gang Min Hur
Journal:  BMC Cancer       Date:  2008-05-23       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.